TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children's Oncology Group.

Leo Mascarenhas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.